CN101134048A - 一种预防和治疗阿尔茨海默病与衰老的药物 - Google Patents
一种预防和治疗阿尔茨海默病与衰老的药物 Download PDFInfo
- Publication number
- CN101134048A CN101134048A CNA200710041571XA CN200710041571A CN101134048A CN 101134048 A CN101134048 A CN 101134048A CN A200710041571X A CNA200710041571X A CN A200710041571XA CN 200710041571 A CN200710041571 A CN 200710041571A CN 101134048 A CN101134048 A CN 101134048A
- Authority
- CN
- China
- Prior art keywords
- benfotiamine
- medicine
- coenzyme
- zinc sulfate
- milligram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200710041571 CN101134048B (zh) | 2007-05-31 | 2007-05-31 | 一种预防和治疗阿尔茨海默病与衰老的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200710041571 CN101134048B (zh) | 2007-05-31 | 2007-05-31 | 一种预防和治疗阿尔茨海默病与衰老的药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101134048A true CN101134048A (zh) | 2008-03-05 |
CN101134048B CN101134048B (zh) | 2010-11-10 |
Family
ID=39158500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200710041571 Active CN101134048B (zh) | 2007-05-31 | 2007-05-31 | 一种预防和治疗阿尔茨海默病与衰老的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101134048B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109111478A (zh) * | 2017-06-26 | 2019-01-01 | 上海日馨生物科技有限公司 | 苯磷硫胺衍生物、制备方法及其药物组合物 |
US10947258B1 (en) | 2019-08-23 | 2021-03-16 | Shanghai Rixin Biotechnology Co., Ltd. | Benfotiamine derivatives, method for preparing the same and pharmaceutical composition comprising the same |
WO2022007982A3 (zh) * | 2020-07-10 | 2022-03-03 | 上海日馨医药科技股份有限公司 | 一种药物组合物及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7666442B2 (en) * | 2004-08-31 | 2010-02-23 | Tracie Martyn International, Llc | Topical compositions comprising benfotiamine and pyridoxamine |
-
2007
- 2007-05-31 CN CN 200710041571 patent/CN101134048B/zh active Active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109111478A (zh) * | 2017-06-26 | 2019-01-01 | 上海日馨生物科技有限公司 | 苯磷硫胺衍生物、制备方法及其药物组合物 |
CN109111478B (zh) * | 2017-06-26 | 2021-02-26 | 上海日馨生物科技有限公司 | 苯磷硫胺衍生物、制备方法及其药物组合物 |
CN112933101A (zh) * | 2017-06-26 | 2021-06-11 | 上海日馨生物科技有限公司 | 苯磷硫胺衍生物、制备方法及其药物组合物 |
US10947258B1 (en) | 2019-08-23 | 2021-03-16 | Shanghai Rixin Biotechnology Co., Ltd. | Benfotiamine derivatives, method for preparing the same and pharmaceutical composition comprising the same |
US20210163515A1 (en) * | 2019-08-23 | 2021-06-03 | Shanghai Rixin Biotechnology Co., Ltd. | Benfotiamine derivatives in the treatment of alzheimer's disease |
US11820787B2 (en) * | 2019-08-23 | 2023-11-21 | Shanghai Raising Pharmaceutical Co., Ltd. | Benfotiamine derivatives in the treatment of alzheimer's disease |
WO2022007982A3 (zh) * | 2020-07-10 | 2022-03-03 | 上海日馨医药科技股份有限公司 | 一种药物组合物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101134048B (zh) | 2010-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Segawa | Hereditary progressive dystonia with marked diurnal fluctuation | |
KR101740893B1 (ko) | Akkermansia muciniphila 균에서 유래하는 세포밖 소포를 유효성분으로 함유하는 대사질환의 치료 또는 예방용 조성물 | |
Hernandez-Rodriguez et al. | Role of thrombin in pulmonary fibrosis | |
CN101134048B (zh) | 一种预防和治疗阿尔茨海默病与衰老的药物 | |
Weiss et al. | Interference with central actions of angiotensin II suppresses sodium appetite | |
De La Fuente‐Fernández et al. | VMAT2 binding is elevated in dopa‐responsive dystonia: visualizing empty vesicles by PET | |
CN101884646A (zh) | 一种防治阿尔茨海默病与衰老的药物复合物及其制备方法 | |
CN101317849A (zh) | 一种防治阿尔茨海默病或衰老的药物组合物 | |
CN109674814B (zh) | 一种硫酸软骨素纳米硒的制备方法及其在制备抑制tau蛋白过度磷酸化药物中的应用 | |
CN112094784B (zh) | 一株能够抑制HaCaT细胞异常增殖的副干酪乳杆菌 | |
Tandon et al. | Cholinergic hyperactivity and negative symptoms: behavioral effects of physostigmine in normal controls | |
CN101156843A (zh) | 一种预防和治疗阿尔茨海默病的胶囊剂及其制备方法 | |
CN101491538A (zh) | 锂盐在制备治疗精神兴奋类药物成瘾的药物上的用途 | |
Wlaź et al. | The effect of an acute and 7-day administration of magnesium chloride on magnesium concentration in the serum, erythrocytes, and brain of rats | |
CN108125988A (zh) | 银杏内酯b在抑制小胶质细胞炎症反应减轻阿尔茨海默病症状的应用 | |
Volchegorskii et al. | Cerebroprotective effects of emoxipin, reamberin, and mexidol in alloxan diabetes | |
CN110898062B (zh) | Tak1抑制剂ng25及其衍生物在制备肌营养不良症药物中的应用 | |
ITRM970435A1 (it) | Composizione nutritiva per soggetti in stato di debilitazione causato da stress | |
CN113332327A (zh) | 西洋参黄芪制剂在制备提高免疫力的产品中的应用 | |
CN112618527A (zh) | 一种小分子在制备突变型葡萄膜黑色素瘤药物中的应用 | |
CN104940914A (zh) | 人尿激肽原酶的新用途及含有人尿激肽原酶的药物组合物 | |
US20240024287A1 (en) | Application of anle138b in drug for improving diet-induced insulin resistance | |
Lu et al. | 2-Deoxy-D-glucose ameliorates inflammation and fibrosis in a silicosis mouse model by inhibiting hypoxia-inducible factor-1α in alveolar macrophages | |
CN102631352A (zh) | 熊果酸的医学新用途 | |
Matsuura et al. | P1862 Preeclampsia induces the acquired salt-sensitivity characteristics via the increased vasopressin secretion in postpartum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI RIXIN BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHONGSHAN HOSPITAL ATTACHED TO FUDAN UNIV Effective date: 20101124 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200032 NO. 136, YIXUEYUAN ROAD, SHANGHAI TO: 200031 804, NO. 2, LANE 446, ZHAOJIABANG ROAD, XUHUI DISTRICT, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20101124 Address after: 200031, No. 446, 2 Jia Bang Road, Shanghai, Xuhui District, No. 804 Patentee after: Shanghai Warm-Hearted Biological Technology Co., Ltd. Address before: 200032 No. 136, Shanghai Medical College Road Patentee before: Zhongshan Hospital Affiliated to Fudan University |
|
CP01 | Change in the name or title of a patent holder |
Address after: 804, No. 2, Lane 446, Zhaojiabang Road, Xuhui District, Shanghai 200031 Patentee after: Shanghai Rixin Pharmaceutical Technology Co.,Ltd. Address before: 804, No. 2, Lane 446, Zhaojiabang Road, Xuhui District, Shanghai 200031 Patentee before: Shanghai Ri Xin Biotechnology Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |